Regulatory Milestone FDA clearance for ClearStart SVM segmentation and volumetric measurement indicates a validated product with potential for expanded use in multi-organ oncology planning, providing entry points for upsell to centers performing imaging-guided interventions.

Small Team Advantage Very small employee count suggests agility and potential for personalized customer success, enabling targeted outreach, rapid pilots, and quick onboarding for clinics seeking specialized planning tools.

Integrated Planning Focus on planning, image guidance, and quantitative analysis positions INTIO to bundle software with interventional equipment or protocols, offering bundled solutions to hospitals aiming to streamline interventional oncology workflows.

Revenue Scale Current revenue range and notable funding indicate growth potential; target mid-market hospitals and ambulatory centers expanding interventional oncology programs to leverage software that improves planning accuracy and outcomes.

Tech Stack Fit Web-centric tech stack (WordPress, PHP, JavaScript) suggests ease of integration with existing hospital IT ecosystems and potential for cloud-based or on-premise deployment models appealing to buyer organizations prioritizing interoperability.